市場調査レポート

商品コード

1587793

全エクソームシーケンシング市場規模、シェア、動向分析レポート：製品別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2024年10月08日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 857,157円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,001,217円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,289,337円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

全エクソームシーケンシング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の全エクソームシーケンシング市場規模は2030年までに12億7,250万米ドルに達し、2024年から2030年にかけて18.44％のCAGRで成長すると予測されています。

市場を牽引する主な要因の1つは、全エクソームシーケンシング技術の進歩です。ハイスループット技術は臨床診断や研究に広く使用されるようになっており、医師がエクソーム配列障害をよりよく理解し、それに応じた治療を行うのに役立っています。さらに、遺伝的疾患の有病率の上昇により、タンパク質コード領域の調査や遺伝的変異に関する貴重なアウトプットの導出のための全エクソームシーケンシングの採用が可能になった。

さらに、全エクソームを含む調査が大幅に増加した背景には、データ解析および解釈ソフトウェアが利用可能になったことがあります。遺伝子データを調べるためにこれらのツールやソフトウェアを使用することは容易であり、遺伝子異常や疾患の根本的な原因に関する新鮮な洞察を提供します。例えば、2022年5月、イルミナの子会社であるグレイルは、米国退役軍人省との提携を発表し、同社のGalleriマルチがん早期発見検査を米国の退役軍人に提供します。この検査は全エクソーム配列を利用し、複数の種類のがんを初期段階で検出します。このパートナーシップは、全エクソームシーケンシングと高度なデータ解析ツールの利用がいかに大規模なゲノム研究を可能にし、精密医療の未来を変えるかを例証するものです。

市場はCOVID-19の大流行によって大きな影響を受けています。ウイルスとその伝播の理解を深めるために全エクソームが使用された例として、COVID-19 Genomics UK Consortium研究があります。パンデミックはまた、感染症との闘いにおけるエクソーム配列の有望性に注目を集め、この研究分野への追加投資に拍車をかけた。2020年のパンデミックによってもたらされた困難にもかかわらず、市場全体は今後数年で発展すると予想されます。

全エクソームシーケンシング市場レポートハイライト

消耗品セグメントは2024年の市場シェア62.36%で市場を独占しました。これは、全エクソームシーケンシングには、試薬、キット、サンプル調製用消耗品など、全エクソームシーケンシング調査の実施に不可欠なさまざまな消耗品が必要なためです。
2024年の市場シェアは、合成によるシーケンスセグメントが73.49%で優位を占めました。これは、合成によるシーケンシングアプローチの有効性と手頃な価格がその魅力を高めているためです。
遺伝子検査サービスや個別化医療に対する需要の高まりにより、2024年の市場シェアは49.90%でシーケンスセグメントが圧倒的な存在感を示しました。全エクソームシーケンシングは、少ないコストで大量の遺伝子データを解析する能力を有し、さらに遺伝子変異のより包括的な解析を可能にします。
新薬の開発を進める上で重要な役割を担っているため、2024年の市場シェアは創薬・開発分野が47.38%で優位を占めました。全エクソームシーケンシングは、遺伝子の変異や病気の原因となる変異を特定するための有力な手法となっており、これを利用することでオーダーメイドの治療法を開発することができます。
全エクソームシーケンシング市場における学術・研究機関セグメントは、2024年に47.32%のシェアで市場を独占しました。このセグメントの優位性は、個別化された医薬品とヘルスケアに対する需要の増加によるものです。

セグメントダッシュボード
全エクソームシーケンシング市場：最終用途変動分析
全エクソームシーケンシング市場規模と動向分析、最終用途別、2018～2030年
学術研究機関
病院・クリニック
製薬・バイオテクノロジー企業
その他

第9章地域別ビジネス分析

地域別市場シェア分析、2024年および2030年
地域市場ダッシュボード
北米
- 北米の全エクソームシーケンシング市場、2018年-2030年
- 米国
- カナダ
- メキシコ
欧州
- 欧州の全エクソームシーケンシング市場、2018年-2030年
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- アジア太平洋地域の全エクソームシーケンシング市場、2018年-2030年
- 日本
- 中国
- インド
- オーストラリア
- タイ
- 韓国
ラテンアメリカ
- ラテンアメリカの全エクソームシーケンシング市場、2018年-2030年
- ブラジル
- アルゼンチン
中東・アフリカ
- 中東・アフリカ全エクソームシーケンシング市場、2018-2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第10章競合情勢

企業分類
戦略マッピング
企業市場シェア分析、2024年
企業プロファイル/
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Agilent Technologies, Inc
- BGI
- PacBio
- Oxford Nanopore Technologies plc.
- Azenta US Inc.（GENEWIZ）
- CD Genomics
- Novogene Co, Ltd
- Eurofins Genomics

図表

List of Tables

Table 1 List of abbreviations
Table 2 Global whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 3 Global whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 4 Global whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 5 Global whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 6 Global whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 7 Global whole exome sequencing market, by region, 2018 - 2030 (USD Million)
Table 8 North America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 9 North America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 10 North America Whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 11 North America Whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 12 North America Whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 13 North America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 14 U.S. whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 16 U.S. whole Exome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
Table 17 U.S. whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 18 U.S. whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 20 Canada whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 21 Canada whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 22 Canada whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 23 Canada whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 24 Mexico whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 25 Mexico whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 26 Mexico whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 27 Mexico whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 28 Mexico whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 29 Europe whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 30 Europe whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 31 Europe whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 32 Europe whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 33 Europe whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 34 Europe whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 35 UK whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 36 UK whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 37 UK whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 38 UK whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 39 UK whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 40 Germany whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 41 Germany whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 42 Germany whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 43 Germany whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 44 Germany whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 45 France whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 46 France whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 47 France whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 48 France whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 49 France whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 50 Italy whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 51 Italy whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 52 Italy whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 53 Italy whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 54 Italy whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 55 Spain whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 56 Spain whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 57 Spain whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 58 Spain whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 59 Spain whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 60 Denmark whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 61 Denmark whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 62 Denmark whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 63 Denmark whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 64 Denmark whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Sweden whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 66 Sweden whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 67 Sweden whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 68 Sweden whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 69 Sweden whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 70 Norway whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 71 Norway whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 72 Norway whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 73 Norway whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 74 Norway whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 76 Asia Pacific whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 77 Asia Pacific whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 78 Asia Pacific whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 79 Asia Pacific whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 80 Asia Pacific whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 81 Japan whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 82 Japan whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 83 Japan whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 84 Japan whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 85 Japan whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 86 China whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 87 China whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 88 China whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 89 China whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 90 China whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 91 India whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 92 India whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 93 India whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 94 India whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 95 India whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 96 Australia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 97 Australia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 98 Australia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 99 Australia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 100 Australia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 101 Thailand whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 102 Thailand whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 103 Thailand whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 104 Thailand whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 105 Thailand whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 106 South Korea whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 107 South Korea whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 108 South Korea whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 109 South Korea whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 110 South Korea whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 111 Latin America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 112 Latin America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 113 Latin America whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 114 Latin America whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 115 Latin America whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 116 Latin America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 117 Brazil whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 118 Brazil whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 119 Brazil whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 120 Brazil whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 121 Brazil whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 122 Argentina whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 123 Argentina whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 124 Argentina whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 125 Argentina whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 126 Argentina whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 127 Middle East & Africa whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 133 South Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 134 South Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 135 South Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 136 South Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 137 South Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 143 UAE whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 144 UAE whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 145 UAE whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 146 UAE whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 147 UAE whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 148 Kuwait whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 149 Kuwait whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 150 Kuwait whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 151 Kuwait whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 152 Kuwait whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Global whole exome sequencing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Global whole exome sequencing market driver analysis
Fig. 12 Global whole exome sequencing market restraint analysis
Fig. 13 Global whole exome sequencing market: Porter's analysis
Fig. 14 Global whole exome sequencing market: PESTEL analysis
Fig. 15 Global whole exome sequencing market: Product movement analysis
Fig. 16 Global whole exome sequencing market, for instruments, 2018 - 2030 (USD Million)
Fig. 17 Global whole exome sequencing market, for consumables, 2018 - 2030 (USD Million)
Fig. 18 Global whole exome sequencing market, for services, 2018 - 2030 (USD Million)
Fig. 19 Global whole exome sequencing market: Technology movement analysis
Fig. 20 Global whole exome sequencing market, for sequencing by synthesis, 2018 - 2030 (USD Million)
Fig. 21 Global whole exome sequencing market, for ION semiconductor sequencing, 2018 - 2030 (USD Million)
Fig. 22 Global whole exome sequencing market, for other technology, 2018 - 2030 (USD Million)
Fig. 23 Global whole exome sequencing market: Workflow movement analysis
Fig. 24 Global whole exome sequencing market, for pre-sequencing, 2018 - 2030 (USD Million)
Fig. 25 Global whole exome sequencing market, for sequencing, 2018 - 2030 (USD Million)
Fig. 26 Global whole exome sequencing market, for data analysis, 2018 - 2030 (USD Million)
Fig. 27 Global whole exome sequencing market: Application movement analysis
Fig. 28 Global whole exome sequencing market, for clinical diagnostics, 2018 - 2030 (USD Million)
Fig. 29 Global whole exome sequencing market, for drug discovery & development, 2018 - 2030 (USD Million)
Fig. 30 Global whole exome sequencing market, for personalized medicine, 2018 - 2030 (USD Million)
Fig. 31 Global whole exome sequencing market, for other applications, 2018 - 2030 (USD Million)
Fig. 32 Global whole exome sequencing market: End use movement analysis
Fig. 33 Global whole exome sequencing market, for academic & research institutes, 2018 - 2030 (USD Million)
Fig. 34 Global whole exome sequencing market, for hospitals & clinics, 2018 - 2030 (USD Million)
Fig. 35 Global whole exome sequencing market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
Fig. 36 Global whole exome sequencing market, for other end use, 2018 - 2030 (USD Million)
Fig. 37 Regional marketplace: Key takeaways
Fig. 38 Regional outlook, 2024 & 2030
Fig. 39 Global whole exome sequencing market: Region movement analysis
Fig. 40 North America whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 41 U.S. whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 42 Canada whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 43 Mexico whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 44 Europe whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 45 Germany whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 46 UK whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 47 France whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 48 Italy whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 49 Spain whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 50 Denmark whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 51 Sweden whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 52 Norway whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 54 Japan whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 55 China whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 56 India whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 57 Australia whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 58 South Korea whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 59 Thailand whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 60 Latin America whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 61 Brazil whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 62 Argentina whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 63 Middle East and Africa whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 64 South Africa whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 66 UAE whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 67 Kuwait whole exome sequencing market, 2018 - 2030 (USD Million)

Product Code: GVR-4-68040-070-5

Whole Exome Sequencing Market Growth & Trends:

The global whole exome sequencing market size is expected to reach USD 1,272.5 million by 2030, registering to grow at a CAGR of 18.44% from 2024 to 2030 according to a new report by Grand View Research, Inc. One of the primary factors driving the market is the advancement in technology for whole exome sequencing. High throughput technology is becoming more widely used in clinical diagnostics and research which helps doctors to better understand the exome sequence disorders and made a treatment accordingly. Additionally, the rising prevalence of genetic conditions has enabled the adoption of whole exome sequencing for the investigation of protein coding regions and the derivation of valuable output about genetic variants.

Additionally, the significant increase in research including whole exomes is driven by the availability of data analysis and interpretation software. The use of these tools and software to examine genetic data is easy and it provides a fresh insight into the underlying causes of genetic abnormalities and diseases. For instance, in May 2022, Illumina's subsidiary Grail, announced a partnership with the U.S. Department of Veterans Affairs, to provide their Galleri multi-cancer early detection test to U.S. veterans. This test utilizes whole exome sequences to detect multiple types of cancer in the early stages. This partnership exemplifies how the usage of whole exome sequencing and advanced data analysis tools can enable large-scale genomic research and transform the future of precision medicine.

The market has been significantly impacted by the COVID-19 pandemic. An example of how whole exomes have been used to better understand the virus and its dissemination is the COVID-19 Genomics UK Consortium study. The pandemic has also brought attention to the promise of exome sequence in the fight against infectious diseases, spurring additional investment in this field of study. The entire market is anticipated to develop in the upcoming years despite difficulties brought on by the pandemic in 2020.

Whole Exome Sequencing Market Report Highlights:

The consumables segment dominated the market in 2024 with a market share of 62.36%. This is due to whole exome sequencing's requirement of a variety of consumable items, including reagents, kits, and sample preparation consumables, which are essential for conducting whole exome sequencing investigations.
Sequencing by synthesis segment dominated the market in 2024 with a market share of 73.49%. This is due to the effectiveness and affordability of the sequencing by synthesis approach that has increased its appeal.
The sequencing segment had a dominating presence in the market in 2024 with a market share of 49.90%, due to the growing demand for genetic testing services and personalized medicine. Whole exome sequencing has the ability to analyze large number of genetic data in a less cost, additionally it allows for more comprehensive analysis of genetic variation.
Drug discovery & development segment dominated the market in 2024 with a market share of 47.38% due to it plays a crucial part in advancing the development of new drugs. Whole exome sequencing has become a compelling method for locating gene variations and disease-causing mutations that can be exploited to create tailored treatments.
The academic & research institutes segment in whole exome sequencing market dominated the market in 2024, with a share of 47.32%. The dominance of the segment is due to the increasing demand for personalized medicines and healthcare.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
  - 1.1.1.1. Product Segment
  - 1.1.1.2. Technology Segment
  - 1.1.1.3. Workflow Segment
  - 1.1.1.4. Application Segment
  - 1.1.1.5. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Growing Prevalence of Genetic Diseases
  - 3.2.1.2. Technological Advancements in Sequencing Platforms and Data Analysis Tools
  - 3.2.1.3. Decreasing Costs of Sequencing
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High Complexity and Costs Associated with Data Storage, Interpretation & Analysis
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

4.1. Segment Dashboard
4.2. Whole Exome Sequencing Market: Product Movement Analysis
4.3. Whole Exome Sequencing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Instruments
- 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
4.5. Consumables
- 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
4.6. Services
- 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

5.1. Segment Dashboard
5.2. Whole Exome Sequencing Market: Technology Movement Analysis
5.3. Whole Exome Sequencing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Sequencing by Synthesis
- 5.4.1. Sequencing By Synthesis Market, 2018 - 2030 (USD Million)
5.5. ION Semiconductor Sequencing
- 5.5.1. ION Semiconductor Sequencing Market, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Other Technology Market, 2018 - 2030 (USD Million)

Chapter 6. Workflow Business Analysis

6.1. Segment Dashboard
6.2. Whole Exome Sequencing Market: Workflow Movement Analysis
6.3. Whole Exome Sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.4. Pre-Sequencing
- 6.4.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
6.5. Sequencing
- 6.5.1. Sequencing Market, 2018 - 2030 (USD Million)
6.6. Others
- 6.6.1. Other Workflow Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

7.1. Segment Dashboard
7.2. Whole Exome Sequencing Market: Application Movement Analysis
7.3. Whole Exome Sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Clinical Diagnostics
- 7.4.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
7.5. Drug Discovery & Development
- 7.5.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
7.6. Personalized Medicines
- 7.6.1. Personalized Medicines Market, 2018 - 2030 (USD Million)
7.7. Others
- 7.7.1. Other Application Market, 2018 - 2030 (USD Million)

Chapter 8. End Use Business Analysis

8.1. Segment Dashboard
8.2. Whole Exome Sequencing Market: End Use Movement Analysis
8.3. Whole Exome Sequencing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Academic And Research Institutes
- 8.4.1. Academic And Research Institutes Market, 2018 - 2030 (USD Million)
8.5. Hospitals & Clinics
- 8.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
8.6. Pharmaceutical & Biotechnology Companies
- 8.6.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
8.7. Others
- 8.7.1. Other End use Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. North America
- 9.3.1. North America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Target Disease Prevalence
  - 9.3.2.3. Competitive Scenario
  - 9.3.2.4. Regulatory Framework
  - 9.3.2.5. U.S. Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Target Disease Prevalence
  - 9.3.3.3. Competitive Scenario
  - 9.3.3.4. Regulatory Framework
  - 9.3.3.5. Canada Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.4. Mexico
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Target Disease Prevalence
  - 9.3.4.3. Competitive Scenario
  - 9.3.4.4. Regulatory Framework
  - 9.3.4.5. Mexico Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4. Europe
- 9.4.1. Europe Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.2. UK
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Target Disease Prevalence
  - 9.4.2.3. Competitive Scenario
  - 9.4.2.4. Regulatory Framework
  - 9.4.2.5. UK Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.3. Germany
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Target Disease Prevalence
  - 9.4.3.3. Competitive Scenario
  - 9.4.3.4. Regulatory Framework
  - 9.4.3.5. Germany Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.4. France
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Target Disease Prevalence
  - 9.4.4.3. Competitive Scenario
  - 9.4.4.4. Regulatory Framework
  - 9.4.4.5. France Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Target Disease Prevalence
  - 9.4.5.3. Competitive Scenario
  - 9.4.5.4. Regulatory Framework
  - 9.4.5.5. Italy Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Target Disease Prevalence
  - 9.4.6.3. Competitive Scenario
  - 9.4.6.4. Regulatory Framework
  - 9.4.6.5. Spain Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Target Disease Prevalence
  - 9.4.7.3. Competitive Scenario
  - 9.4.7.4. Regulatory Framework
  - 9.4.7.5. Denmark Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key Country Dynamics
  - 9.4.8.2. Target Disease Prevalence
  - 9.4.8.3. Competitive Scenario
  - 9.4.8.4. Regulatory Framework
  - 9.4.8.5. Sweden Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key Country Dynamics
  - 9.4.9.2. Target Disease Prevalence
  - 9.4.9.3. Competitive Scenario
  - 9.4.9.4. Regulatory Framework
  - 9.4.9.5. Norway Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5. Asia Pacific
- 9.5.1. Asia Pacific Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.2. Japan
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Target Disease Prevalence
  - 9.5.2.3. Competitive Scenario
  - 9.5.2.4. Regulatory Framework
  - 9.5.2.5. Japan Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.3. China
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Target Disease Prevalence
  - 9.5.3.3. Competitive Scenario
  - 9.5.3.4. Regulatory Framework
  - 9.5.3.5. China Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.4. India
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Target Disease Prevalence
  - 9.5.4.3. Competitive Scenario
  - 9.5.4.4. Regulatory Framework
  - 9.5.4.5. India Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.5. Australia
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Target Disease Prevalence
  - 9.5.5.3. Competitive Scenario
  - 9.5.5.4. Regulatory Framework
  - 9.5.5.5. Australia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.6. Thailand
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Target Disease Prevalence
  - 9.5.6.3. Competitive Scenario
  - 9.5.6.4. Regulatory Framework
  - 9.5.6.5. Thailand Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.7. South Korea
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Target Disease Prevalence
  - 9.5.7.3. Competitive Scenario
  - 9.5.7.4. Regulatory Framework
  - 9.5.7.5. South Korea Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6. Latin America
- 9.6.1. Latin America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.6.2. Brazil
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Target Disease Prevalence
  - 9.6.2.3. Competitive Scenario
  - 9.6.2.4. Regulatory Framework
  - 9.6.2.5. Brazil Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Target Disease Prevalence
  - 9.6.3.3. Competitive Scenario
  - 9.6.3.4. Regulatory Framework
  - 9.6.3.5. Argentina Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.7. MEA
- 9.7.1. MEA Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.7.2. South Africa
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Target Disease Prevalence
  - 9.7.2.3. Competitive Scenario
  - 9.7.2.4. Regulatory Framework
  - 9.7.2.5. South Africa Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.7.3. Saudi Arabia
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Target Disease Prevalence
  - 9.7.3.3. Competitive Scenario
  - 9.7.3.4. Regulatory Framework
  - 9.7.3.5. Saudi Arabia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.7.4. UAE
  - 9.7.4.1. Key Country Dynamics
  - 9.7.4.2. Target Disease Prevalence
  - 9.7.4.3. Competitive Scenario
  - 9.7.4.4. Regulatory Framework
  - 9.7.4.5. UAE Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 9.7.5. Kuwait
  - 9.7.5.1. Key Country Dynamics
  - 9.7.5.2. Target Disease Prevalence
  - 9.7.5.3. Competitive Scenario
  - 9.7.5.4. Regulatory Framework
  - 9.7.5.5. Kuwait Whole Exome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Share Analysis, 2024
10.4. Company Profiles/Listing
- 10.4.1. Thermo Fisher Scientific, Inc.
  - 10.4.1.1. Overview
  - 10.4.1.2. Financial Performance
  - 10.4.1.3. Product Benchmarking
  - 10.4.1.4. Strategic Initiatives
- 10.4.2. Illumina, Inc.
  - 10.4.2.1. Overview
  - 10.4.2.2. Financial Performance
  - 10.4.2.3. Product Benchmarking
  - 10.4.2.4. Strategic Initiatives
- 10.4.3. Agilent Technologies, Inc
  - 10.4.3.1. Overview
  - 10.4.3.2. Financial Performance
  - 10.4.3.3. Product Benchmarking
  - 10.4.3.4. Strategic Initiatives
- 10.4.4. BGI
  - 10.4.4.1. Overview
  - 10.4.4.2. Financial Performance
  - 10.4.4.3. Product Benchmarking
  - 10.4.4.4. Strategic Initiatives
- 10.4.5. PacBio
  - 10.4.5.1. Overview
  - 10.4.5.2. Financial Performance
  - 10.4.5.3. Product Benchmarking
  - 10.4.5.4. Strategic Initiatives
- 10.4.6. Oxford Nanopore Technologies plc.
  - 10.4.6.1. Overview
  - 10.4.6.2. Financial Performance
  - 10.4.6.3. Product Benchmarking
  - 10.4.6.4. Strategic Initiatives
- 10.4.7. Azenta US Inc. (GENEWIZ)
  - 10.4.7.1. Overview
  - 10.4.7.2. Financial Performance
  - 10.4.7.3. Product Benchmarking
  - 10.4.7.4. Strategic Initiatives
- 10.4.8. CD Genomics
  - 10.4.8.1. Overview
  - 10.4.8.2. Financial Performance
  - 10.4.8.3. Product Benchmarking
  - 10.4.8.4. Strategic Initiatives
- 10.4.9. Novogene Co, Ltd
  - 10.4.9.1. Overview
  - 10.4.9.2. Financial Performance
  - 10.4.9.3. Product Benchmarking
  - 10.4.9.4. Strategic Initiatives
- 10.4.10. Eurofins Genomics
  - 10.4.10.1. Overview
  - 10.4.10.2. Financial Performance
  - 10.4.10.3. Product Benchmarking
  - 10.4.10.4. Strategic Initiatives

全エクソームシーケンシング市場規模、シェア、動向分析レポート：製品別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

全エクソームシーケンシング市場の成長と動向：

全エクソームシーケンシング市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場の変数、動向、範囲

第4章製品別ビジネス分析

第5章技術別ビジネス分析

第6章ワークフロー別ビジネス分析

第7章用途別ビジネス分析

第8章最終用途別ビジネス分析

第9章地域別ビジネス分析

第10章競合情勢

List of Tables

List of Figures

Whole Exome Sequencing Market Growth & Trends:

Whole Exome Sequencing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Product Business Analysis

Chapter 5. Technology Business Analysis

Chapter 6. Workflow Business Analysis

Chapter 7. Application Business Analysis

Chapter 8. End Use Business Analysis

Chapter 9. Regional Business Analysis

Chapter 10. Competitive Landscape

全エクソームシーケンシング市場規模、シェア、動向分析レポート：製品別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

全エクソームシーケンシング市場の成長と動向：

全エクソームシーケンシング市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

第4章 製品別ビジネス分析

第5章 技術別ビジネス分析

第6章 ワークフロー別ビジネス分析

第7章 用途別ビジネス分析

第8章 最終用途別ビジネス分析

第9章 地域別ビジネス分析

第10章 競合情勢

List of Tables

List of Figures

Whole Exome Sequencing Market Growth & Trends:

Whole Exome Sequencing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Product Business Analysis

Chapter 5. Technology Business Analysis

Chapter 6. Workflow Business Analysis

Chapter 7. Application Business Analysis

Chapter 8. End Use Business Analysis

Chapter 9. Regional Business Analysis

Chapter 10. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場の変数、動向、範囲

第4章製品別ビジネス分析

第5章技術別ビジネス分析

第6章ワークフロー別ビジネス分析

第7章用途別ビジネス分析

第8章最終用途別ビジネス分析

第9章地域別ビジネス分析

第10章競合情勢